Form 4: CareDx Executive's Future Stock Sale for Tax Obligations

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reported a future disposition of 2,872 common shares to cover tax liabilities from restricted stock unit vesting.

Summary

• Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc. (CDNA), filed a Form 4.
• The filing reports a planned disposition of 2,872 shares of CareDx common stock.
• The transaction is scheduled for November 1, 2025, at a price of $14.77 per share.
• These shares will be withheld by CareDx to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, Novack will beneficially own 110,058 shares of common stock.
• The transaction is made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c) conditions.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary transaction for tax withholding purposes, which is neutral in sentiment.

Future Outlook

This filing details a pre-planned future transaction for tax purposes and does not provide forward-looking statements regarding company performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary sale for tax purposes, not indicative of a change in insider sentiment or company fundamentals.

Key Dates

Keywords

CareDx, CDNA, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Jeffrey Adam Novack, Restricted Stock Units, 10b5-1 Plan